Creditors of an Australian biotechnology firm that racked up more than $8m in liabilities have approved a multimillion-dollar ...
TAIPEI, March 17, 2025 /PRNewswire/ -- Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications for ...
Visit a quote page and your recently viewed tickers will be displayed here.
CUPERTINO, Calif., Dec. 16, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in ...
Microbio (4128) has delivered a -34.49% change over the past year, with a 52-week range between 14.20 and 30.30. What Is the Average Daily Trading Volume of Microbio (4128)? The average daily trading ...
Microbio has developed a pathogen test to help identify “a silent killer” that is notoriously difficult to predict, diagnose and treat. Brisbane medtech scale-up Microbio has developed a game-changing ...
Aaa Aaaaaaaa Aaaaa 4,526.0 +26.68% 5,733.5 ...
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer ...
4147.TWO TaiMed Biologics Inc.
Visit a quote page and your recently viewed tickers will be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results